High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanomaAlexander T. Faje, Ryan J. Sullivan, Riley Fadden et al.|Cancer|2018Cited by 481
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)Kevin Kalinsky, John M. Kirkwood, Krista M. Rubin et al.|Cancer|2017Cited by 125